Back to search

Orfonyx Bio Ltd

14212968

active
ltd
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

Bioescalator Innovation Building, Roosevelt Drive, Oxford, OX3 7FZ
Incorporated 04/07/2022

Compliance

Last accounts

31/12/2025

total exemption full

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 03/07/2026

Due 17/07/2027

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Prof Matthew John Andrew Wood

director · Since 04/07/2022

PROFESSOR OF NEUROSCIENCE, UNIVERSITY OF

IRISH · UNITED KINGDOM · Age 63

Also on 2 other boards

Benedict Charles Stephens

secretary · Since 28/07/2022

Dr Claire Brown

director · Since 20/10/2022

INVESTOR

BRITISH · UNITED KINGDOM · Age 55

Also on 4 other boards

Benedicte Menn

director · Since 12/05/2023

PRINCIPAL LICENSING & VENTURES MANAGER

FRENCH · UNITED KINGDOM · Age 53

Lisanne Darunii De Jongh

director · Since 12/05/2023

PARTNER AT OXFORD SCIENCE ENTERPRISES

DUTCH · NETHERLANDS · Age 37

Dr Christian Groendahl

director · Since 01/08/2026

DANISH · DENMARK · Age 62

Matthew John Andrew Wood

director · Since 04/07/2022

Irish · United Kingdom · Age 63

Benedict Charles Stephens

secretary · Since 28/07/2022

Claire Brown

director · Since 20/10/2022

British · United Kingdom · Age 55

Benedicte Menn

director · Since 12/05/2023

French · United Kingdom · Age 53

Lisanne Darunii De Jongh

director · Since 12/05/2023

Dutch · Netherlands · Age 37

Former

Pennsec Limited

corporate secretary · Resigned 28/07/2022

Persons with Significant Control

Oxford Science Enterprises Plc

75–100% shares
75–100% votes

46, Woodstock Road, Oxford, OX2 6HT

Reg: 09093331 · Companies House · Corporate

Notified 20/10/2022

Former PSCs

Nenad Svrzikapa

Ceased 20/10/2022

Prof Matthew John Andrew Wood

Ceased 20/10/2022

Thomas Charles Roberts

Ceased 20/10/2022

Change History

status → active
2026-07-15

Active

type → ltd
2026-07-15

Private Limited Company

address line1 → Bioescalator Innovation Building
2026-07-15

BIOESCALATOR INNOVATION BUILDING

post town → Oxford
2026-07-15

OXFORD

CompanyRankvs 1400+ SIC 72110 peers
56

Financial strength89th percentile among SIC peers · 22/25
Employees87th percentile among SIC peers · 13/15
LiquidityCurrent ratio -9.69× · 2/20
Longevity4 years trading (max 15) · 4/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength22/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity4/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£486k

Balance sheet strength

Cash

£238k

Cash in the bank

Net Current Assets

£313k

Working capital

Current Assets

£284k

Current Liabilities

-£29k

Fixed Assets

£173k

Debtors

£45k

6avg. employees

Balance Sheet

Assets less current liabilities£486k

EstimatesDerived

YearCurrent RatioImplied Profit
20259.69-£361k
20245.90-£693k
20248.42+£1.1M
20234.44—

Derived from filed accounts. Not audited figures.